A "highly reliable (Go-to)" PCR enzyme that combines excellent extensibility while maintaining high accuracy!
The "Go-to DNA Polymerase" we handle is a PCR enzyme that combines α-type DNA polymerase derived from Pyrococcus sp. with a modified elongation enhancer. It possesses 3’→ 5’ exonuclease activity, which allows it to remove incorrectly incorporated nucleotides during the polymerase reaction, making it suitable for applications requiring high accuracy in DNA fragments, such as cloning. Additionally, the modified elongation enhancer improves the shortcomings of α-type DNA polymerase, such as low elongation speed and amplification efficiency. 【Features】 ■ Mixture of α-type DNA polymerase and modified elongation enhancer ■ Faster elongation speed and better DNA amplification efficiency due to the modified elongation enhancer ■ Has proofreading activity, ensuring high accuracy *For more details, please refer to the related links or feel free to contact us.
Inquire About This Product
basic information
【Product Contents (Partial)】 <Go-to DNA Polymerase 125 U (for 50 reactions)> ■Components ・Go-to DNA Polymerase (2.5 U/μl) ・10×Go-to Buffer ・dNTPs Mixture (2.5 mM each) *For more details, please refer to the related links or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
【Usage】 ■Reagents for testing and research purposes *For more details, please refer to the related links or feel free to contact us.
Company information
Our company is a product development-oriented enterprise that utilizes biotechnology. We develop and manufacture in vitro diagnostic pharmaceuticals (such as pregnancy tests and ovulation tests), diagnostic drugs for environmental, food, and animal and plant diseases, and reagents for genetic engineering research, using our expertise in gene and antibody technology. We hold manufacturing registration and manufacturing and sales licenses for both human and animal products, with over 30 years of experience in the manufacture of in vitro diagnostic pharmaceuticals. Additionally, we are engaged in personalized medicine, advancing research and development of diagnostic drugs using genetic polymorphism analysis and gene expression analysis.
